170 related articles for article (PubMed ID: 35135919)
1. The First Case of Gastric Neuroendocrine Tumors Induced by a Proton Pump Inhibitor in von Hippel-Lindau Disease.
Kawaguchi K; Yashima K; Ikebuchi Y; Yoshida A; Kuwamoto S; Isomoto H
Intern Med; 2022 Sep; 61(17):2587-2592. PubMed ID: 35135919
[TBL] [Abstract][Full Text] [Related]
2. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111
[TBL] [Abstract][Full Text] [Related]
4. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis.
Lubensky IA; Pack S; Ault D; Vortmeyer AO; Libutti SK; Choyke PL; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1998 Jul; 153(1):223-31. PubMed ID: 9665483
[TBL] [Abstract][Full Text] [Related]
5. Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease.
Gucer H; Szentgyorgyi E; Ezzat S; Asa SL; Mete O
Virchows Arch; 2013 Oct; 463(4):593-7. PubMed ID: 23913169
[TBL] [Abstract][Full Text] [Related]
6. [Pancreatic neuroendocrine tumors and von Hippel-Lindau disease].
Musso C; Paraf F; Petit B; Archambeaud-Mouveroux F; Valleix D; Labrousse F
Ann Pathol; 2000 Mar; 20(2):130-3. PubMed ID: 10740008
[TBL] [Abstract][Full Text] [Related]
7. Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa.
Tatsuguchi A; Hoshino S; Kawami N; Gudis K; Nomura T; Shimizu A; Iwakiri K
Pathol Res Pract; 2020 Oct; 216(10):153113. PubMed ID: 32853950
[TBL] [Abstract][Full Text] [Related]
8. [Gastroenterological manifestations of von Hippel-Lindau disease - a case report].
Koniusz J; Dąbkowski K; Buczek K; Gomółka A; Starzyńska T
Pol Merkur Lekarski; 2017 Aug; 43(254):66-68. PubMed ID: 28875972
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and treatment of pancreatic neuroendocrine neoplasmas in Von Hippel-Lindau syndrome].
Liu WK; Tian XD; Yang YM
Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):869-872. PubMed ID: 30392308
[TBL] [Abstract][Full Text] [Related]
10. Metastatic renal cell carcinoma versus pancreatic neuroendocrine tumor in von Hippel-Lindau disease: treatment with interleukin-2.
Williams C; Walther M
ScientificWorldJournal; 2005 Jan; 5():9-10. PubMed ID: 15674444
[TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
McCarthy DM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
[TBL] [Abstract][Full Text] [Related]
12. Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease.
Corleto VD; Cotesta D; Petramala L; Panzuto F; Pagnini C; Masoni L; Verrienti A; Delle Fave G; Filetti S; Letizia C
JOP; 2009 Sep; 10(5):562-5. PubMed ID: 19734639
[TBL] [Abstract][Full Text] [Related]
13. Two Childhood Pheochromocytoma Cases due to von Hippel-Lindau Disease, One Associated with Pancreatic Neuroendocrine Tumor: A Very Rare Manifestation.
Dağdeviren Çakır A; Turan H; Aykut A; Durmaz A; Ercan O; Evliyaoğlu O
J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):179-182. PubMed ID: 29022557
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations.
Libutti SK; Choyke PL; Bartlett DL; Vargas H; Walther M; Lubensky I; Glenn G; Linehan WM; Alexander HR
Surgery; 1998 Dec; 124(6):1153-9. PubMed ID: 9854597
[TBL] [Abstract][Full Text] [Related]
15. [Gastroenterological manifestations of von Hippel-Lindau disease].
Koniusz J; Dąbkowski K; Buczek K; Gomółka A; Starzyńska T
Pol Merkur Lekarski; 2017 Aug; 43(254):53-55. PubMed ID: 28875969
[TBL] [Abstract][Full Text] [Related]
16. Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome.
Weisbrod AB; Kitano M; Thomas F; Williams D; Gulati N; Gesuwan K; Liu Y; Venzon D; Turkbey I; Choyke P; Yao J; Libutti SK; Nilubol N; Linehan WM; Kebebew E
J Am Coll Surg; 2014 Feb; 218(2):163-9. PubMed ID: 24440063
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature.
Charlesworth M; Verbeke CS; Falk GA; Walsh M; Smith AM; Morris-Stiff G
J Gastrointest Surg; 2012 Jul; 16(7):1422-8. PubMed ID: 22370733
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing clear cell neuroendocrine tumors on cytological specimens: Report of two cases and brief literature review.
Buckley K; Li Z
Diagn Cytopathol; 2017 Aug; 45(8):757-760. PubMed ID: 28387021
[TBL] [Abstract][Full Text] [Related]
19. Clear cell neuroendocrine tumor of the pancreas in von Hippel-Lindau disease: a case report and literature review.
Woo CG; Choi SY; Kwak JJ; Chin S; Kim HK
Neuro Endocrinol Lett; 2017 May; 38(2):83-86. PubMed ID: 28650600
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison.
Marcos HB; Libutti SK; Alexander HR; Lubensky IA; Bartlett DL; Walther MM; Linehan WM; Glenn GM; Choyke PL
Radiology; 2002 Dec; 225(3):751-8. PubMed ID: 12461257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
